Corpus ID: 15223179

Clinical overview of vasculitic syndromes in the pediatric age.

@article{Rigante2006ClinicalOO,
  title={Clinical overview of vasculitic syndromes in the pediatric age.},
  author={D. Rigante},
  journal={European review for medical and pharmacological sciences},
  year={2006},
  volume={10 6},
  pages={
          337-45
        }
}
  • D. Rigante
  • Published 2006
  • Medicine
  • European review for medical and pharmacological sciences
Vasculitic syndromes comprise a heterogeneous group of disorders sharing the hystopathologic features of inflammation and necrosis in blood vessels. Their clinical expression depends on site, type and size of the involved vessels and severity of the associated inflammatory symptoms. Classification of vasculitides based on the size of the affected vessels is the most widely used in children. Many different vasculitides with indistinguishable clinical presentation have very different prognosis… Expand
PRIMARY SYSTEMIC VASCULITIS IN CHILDHOOD
TLDR
A classification of pediatric vasculitis is proposed, which takes into account the size of the vessels involved, and also validated diagnostic criteria for the types most common in children. Expand
Orbital pseudotumor: A single precursor clinical manifestation of Wegener granulomatosis in a ten year old boy
TLDR
Although WG is very rare in children, this disease should always been included in the differential diagnosis in patients with similar clinical manifestations and clinicians should emphasize on the recognition of granulomatous vasculitis in biopsies as well as on repeated tests for ANCA antibody detection in serum. Expand
Necrosis of mesenteric lymph nodes in Henoch–Schönlein purpura
TLDR
Main HSP manifestations include nonthrombocytopenic purpura, joint involvement of different severity, abdominal pain and renal disease, which usually remit spontaneously, but can recur many times over a period of weeks or months. Expand
Serum Interleukin-18 in Children with Henoch-Schönlein Purpura: A Promising Marker of Disease Activity?
TLDR
The data support the conclusion that serum IL-18 levels reflect HSp activity, and are expected to provide a marker of disease activity or even a prognostic tool in clinical practice. Expand
Intravenous immunoglobulin in Henoch-Schönlein purpura complicated by cerebral hemorrhage
TLDR
The case of an 8-year-old boy admitted to a district hospital with a one-week history of purpuric rash and sudden severe headache and irritability, followed by generalized seizures that required diazepam per rectum is reported. Expand
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease
TLDR
The application of these recommendations should improve prognosis of Kawasaki disease and prevent the progression to permanent vascular abnormalities, thereby diminishing morbidity and mortality. Expand
Interstitial lung diseases in children
TLDR
Current concepts of pathophysiological mechanisms, etiology and diagnostic approaches, as well as therapeutic strategies are reviewed, to discuss the various causes of pediatric ILD specific to infancy. Expand
A Child with Fever, Lymphadenitis and Rash
TLDR
A 7-year-old female presented with sustained fever for 1 week, not responding to antibiotics, associated with generalized erythema multiforme-like lesions and pustular lesions, and clinical examination revealed conjunctival injection, cervical lymphadenopathy, and hepatomegaly. Expand
CTLA-4 exon 1 +49A/G polymorphism is associated with renal involvement in pediatric Henoch–Schönlein purpura
TLDR
Findings suggest that the CTLA-4 +49 GG genotype and G allele may contribute to increased risk for the development of renal damage in HSP patients. Expand
Correlation of TLR2 and TLR4 expressions in peripheral blood mononuclear cells to Th1- and Th2-type immune responses in children with henoch-schönlein purpura.
TLDR
TLR2 and TLR4 overactivation may induce HSP-related renal impairment; Children with HSP showed T-cell disorders and Th1/Th2 imbalance. Expand
...
1
2
...

References

SHOWING 1-10 OF 27 REFERENCES
Vasculitis of the nervous system
  • D. Younger
  • Medicine
  • Current opinion in neurology
  • 2004
TLDR
Clinicians must choose from among the available immunomodulating, immunosuppressive, and targeted immunotherapies, unfortunately without the benefit of prospective clinical trials, tempered by the recognition of all of the possible medication related side effects. Expand
Small-vessel vasculitis.
TLDR
Protean clinical manifestations, combined with the etiologic nonspecificity of the histologic lesions, complicate the diagnosis of specific forms of vasculitis. Expand
Wegener granulomatosis in childhood and adolescence
TLDR
Introduction of combined treatment with cyclophosphamide and glucocorticoids resulted in a dramatic improvement of patient outcome; however, commonly occurring disease relapses and the risk of chronic organ damage at all ages make long-term follow-up of all patients and the establishment of new therapeutic regimens necessary. Expand
Recent progress in the pharmacotherapy of Churg-Strauss syndrome
TLDR
In patients with severe disease and organ- or life-threatening manifestation, the addition of cyclophosphamide appears to improve the outcome and reduces the incidence of relapses, in patients with an apparently better prognosis and less severe disease, methotrexate can be given as a corticosteroid-sparing agent. Expand
Juvenile polyarteritis: results of a multicenter survey of 110 children.
TLDR
There were remarkable differences among pediatric patients with PAN, with different clinical manifestations and overall better survival and lower relapse rates when compared with adults. Expand
Childhood microscopic polyangiitis associated with MPO-ANCA
TLDR
Six girls and one boy aged 12.0±2.6 years (7–15 years) met the following inclusion criteria: clinical manifestations of systemic small vessel involvement; histological demonstration of pauci-immune necrotizing glomerulonephritis; and serological findings of increased concentration of MPO-ANCA by ELISA test. Expand
Cerebral vasculitis and intracerebral hemorrhage in Henoch-Schönlein purpura treated with plasmapheresis
TLDR
It is proposed that plasmapheresis is a reliable and effective therapy and may be considered as the first-line treatment in this critical condition to prevent massive intracerebral hemorrhagic complication of this immune complex-mediated cerebral vasculitis leading to irreversible neurological sequelae or mortality. Expand
Are polymyalgia rheumatica and giant cell arteritis the same disease?
TLDR
The evidence about the relationship between polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) is summarized, suggesting that PMR and GCA are closely related conditions affecting people over 50 years and frequently occurring in the same patient. Expand
Incidence of vasculitis in children in the Czech Republic: 2-year prospective epidemiology survey.
TLDR
Henoch-Schonlein purpura was the most common, with a relatively high proportion of the patients treated with a short course of corticosteroids, and other childhood vasculitides were rare. Expand
Churg–Strauss syndrome: successful treatment with mycophenolate mofetil
TLDR
Surgical excision of the lesion, with or without antifungal therapy, has been shown to be associated with better outcome and is the treatment of choice for isolated skin lesions in immunocompetent patients. Expand
...
1
2
3
...